ArticleCurrent research in structural biology2026
Ligand-specific conformational dynamics and interaction landscapes of hnRNPA2B1 reveal a structural basis for its functional regulation.
Article in Current research in structural biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The RNA-binding protein hnRNPA2B1 is critical for mRNA processing, transport, metabolism, and antiviral innate immunity. Its activity is modulated by various ligands, including RNA, single-stranded DNA (ssDNA), and the small-molecule agonist PAC5, but the structural dynamics of these ligand-specific modulations are not fully understood. We hypothesized that each ligand triggers distinct conformational shifts that dictate functional outcomes. Starting from available crystal structures, we built three complex models and performed 100-ns molecular-dynamics simulations, analyzing RMSD, RMSF, radius of gyration, free-energy landscapes, MM/PBSA binding affinities, PCA projections, and trajectory clustering. Our analyses reveal common and distinct interaction footprints between hnRNPA2B1 and the three ligands. Residues 24, 62, and 97 engage all ligands, whereas residues 28 and 30 form pronounced contacts with ssDNA yet only weakly interact with RNA and PAC5. Conversely, residues 102 and 108 are stably anchored to RNA but not to ssDNA. Radius-of-gyration and RMSF analyses further indicate that the backbone flexibility of hnRNPA2B1 is ligand-dependent: the protein is most expanded when bound to PAC5 and most compact when bound to ssDNA. Consistently, the binding free energy is highest for PAC5 and lowest for ssDNA. Finally, PCA shows that the PAC5-bound ensemble splits into two distinct conformational clusters whose overlap with the ssDNA-bound state (39.26 %) markedly exceeds that with the RNA-bound state (16.12 %), suggesting that PAC5 may promote hnRNPA2B1 dimerization by mimicking the ssDNA-bound conformation. These findings illuminate the ligand-dependent conformational and interaction landscapes of hnRNPA2B1, establishing a robust structure-thermodynamics framework for rational drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.